EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database ,

ISSN 2394-3211

Impact Factor: 6.222

ICV - 79.57

Abstract

SYNTHESIS OF SOME DIHYDROPYRIMIDINE DERIVATIVES CARRYING 1,3,4-OXADIAZOLE MOIETY AS ANTICANCER AGENTS

Shada H. Yassin, Tawfeek A. Yahya* and Jalal H. Abdullah

ABSTRACT

A series of dihydropyrimidines (4a-d) were synthesized by reaction of 3,4-dihydropyrimidine-2(1H)-thione (3a-d) with 2-(chloromethyl)-5-chlorophenyl-1,3,4-oxadiazole. The compound 4b showed the highest anticancer activity (IC50= 28.2 µM) when compared to standard drug doxorubicin (IC50= 36.3 µM).

Keywords: Chalcone, Dihydropyrimidine, 1,3,4-Oxadiazole, HEPG2, Anticancer.

[Full Text Article]

SJIF Impact Factor: 6.222

INDEXING

Indexing

LOGIN

NEWS & UPDATION

New Issue Published
Its Our pleasure to inform you that, EJPMR 1 September 2023 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

EJPMR: SEPTEMBER ISSUE PUBLISHED
SEPTEMBER issue has been successfully launched on 1 SEPTEMBER 2023.

EJPMR New Impact Factor
Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from 5.804 to 6.222, due to high quality Publication at International Level